Severe central nervous system demyelination in Sanfilippo disease.

"Conflict of interest AVP was a shareholder and received honoraria and research contracts from Phoenix Nest Inc involved in development of therapies for MPS IIID and IIIC. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work has been partially supported by operating grants PJT-156345 and PJT-180546 from the Canadian Institutes of Health Research and a research grant ND-1 from the Canadian Glycomics Network to AVP and GL, Elisa Linton Research Chair in Lysosomal Diseases and gifts from Cure Sanfilippo Foundation and Sanfilippo Children’s Foundation (Australia) to AVP and GL was supported by a salary award from FRQ-S."